SC 13D

Company

Viridian Therapeutics, Inc.\DE

Filed

February 23, 2017

Accession Number

0001104659-17-011148

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →